>> The Pharma Congress: > Speakers

• Dr Friedrich Haefele, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach
  In May 2006 Dr Haefele joined Boehringer-Ingelheim Pharma as Vice President in the business domain Biopharmaceuticals.
• Dr. Martin Haerer, Holopack Verpackungstechnik GmbH, Abtsgemünd-Untergröningen
  Martin Haerer is Director Pharmaceutical Affairs and Qualified Person. He is responsible for Development, Transfer of BFS Products and pharmaceutical customer relationship.
• Brigitte Lechiffre, GETINGE LA Calhene, Vendôme
  As Sales Area Manager responsible for Sales of all DPTE^® configurations to Integrators and OEM companies and the support for transfer applications.
• Dr. Jean-Denis Mallet, International Committee Red Cross, Geneva
  He is currently a GMP auditor within the ICRC. He was previously Head of the Pharmaceutical Inspection Department at the French Health Products Regulatory Agency.
• Herwig Muehleder, Wyeth BioPharma, Dublin, Ireland
  Project engineer and leader in realising Wyeth‘s second Syringe Filling Line with new Skan E-Beam System at Grange Castle near Dublin.
• Dr. Michael Pfeil, Merz Pharma GmbH & Co. KGaA, Reinheim
  Head of Production (Biologics), Merz Group Services GmbH, Site Dessau
• Dr. Ingo Presser, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach
  Since 2007 he has been Head of an Aseptic Filling and Freeze Drying Unit within the department of biopharmaceutical production.
• Hartmut Schaz, NNE Pharmaplan GmbH, Bad Homburg
  He is working with NNE Pharmaplan as a Senior Expert for Small Volume Parenteral Products and is a Director of the Board of NNE Pharmaplan India.
• Dr. Rainer Schmidt, F. Hoffmann-La Roche AG
  Dr Rainer Schmidt is the project owner for building a new parenterals facility for F. Hoffmann-La Roche in Kaiseraugst, Switzerland.
• Dr Christian Schröter, Merck KGaA
  Dr Schröter is currently Director of Liquid Manufacturing responsible for making, filling and packaging of sterile and nonsterile liquids.
• Volker Sigwarth, Skan AG, Allschwil
  As Director Business Development, he headed the engineering and development department; since 2009 he has been CEO of Skan AG.
• Benoît Verjans, Aseptic Technologies S.A., Les Isnes, Belgien
  He is currently Commercial Director of Aseptic Technologies, responsible for developing the sales of the closed vial technology worldwide.
• Jörg Zimmermann, Vetter Pharma-Fertigung GmbH & Co. KG, Ravensburg
  Since 2001, he has been Head of Production at the Langenargen site, where he is in charge of the aseptically prefilled syringes.